These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

823 related articles for article (PubMed ID: 16061001)

  • 1. [The roles of complement 1q and anti-C1q autoantibodies in pathogenesis of lupus nephritis].
    Zhang FC; Zhou B; Dong Y
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):955-9. PubMed ID: 16061001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus.
    Marto N; Bertolaccini ML; Calabuig E; Hughes GR; Khamashta MA
    Ann Rheum Dis; 2005 Mar; 64(3):444-8. PubMed ID: 15286009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis.
    Trendelenburg M; Lopez-Trascasa M; Potlukova E; Moll S; Regenass S; Frémeaux-Bacchi V; Martinez-Ara J; Jancova E; Picazo ML; Honsova E; Tesar V; Sadallah S; Schifferli J
    Nephrol Dial Transplant; 2006 Nov; 21(11):3115-21. PubMed ID: 16877491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Significance of serum anti-Clq Ab in evaluation of lupus nephritis activity and its curative effects of pharmacotherapy on lupus nephritis].
    Cai XY; Yang XY; Chen XH; Liang LQ; Guan MM; Qin SG; Fu JZ
    Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1436-9. PubMed ID: 15500738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgG autoantibodies against C1q are correlated with nephritis, hypocomplementemia, and dsDNA antibodies in systemic lupus erythematosus.
    Siegert C; Daha M; Westedt ML; van der Voort E; Breedveld F
    J Rheumatol; 1991 Feb; 18(2):230-4. PubMed ID: 2023216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
    Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
    Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive value of IgG autoantibodies against C1q for nephritis in systemic lupus erythematosus.
    Siegert CE; Daha MR; Tseng CM; Coremans IE; van Es LA; Breedveld FC
    Ann Rheum Dis; 1993 Dec; 52(12):851-6. PubMed ID: 8311534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between serum anti-C1q antibody levels and renal pathological characteristics and prognostic significance of anti-C1q antibody in lupus nephritis.
    Cai X; Yang X; Lian F; Lin X; Liang M; Li J; Chen X; Liang L; Qin S; Fu J
    J Rheumatol; 2010 Apr; 37(4):759-65. PubMed ID: 20194446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein, immunoglobulin G and complement co-localize in renal immune deposits of proliferative lupus nephritis.
    Sjöwall C; Olin AI; Skogh T; Wetterö J; Mörgelin M; Nived O; Sturfelt G; Bengtsson AA
    Autoimmunity; 2013 May; 46(3):205-14. PubMed ID: 23331132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between the renal C1q deposition and serum anti-C1q antibody: a potential role of anti-C1q antibody in lupus nephritis.
    Chen PC; Wang CR; Liu MF; Chen FF; Liang CC
    Asian Pac J Allergy Immunol; 2002 Dec; 20(4):223-7. PubMed ID: 12744622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical value of autoantibodies against C1q in children with glomerulonephritis.
    Kozyro I; Perahud I; Sadallah S; Sukalo A; Titov L; Schifferli J; Trendelenburg M
    Pediatrics; 2006 May; 117(5):1663-8. PubMed ID: 16651321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complement component c1q and anti-c1q antibodies in theory and in clinical practice.
    Potlukova E; Kralikova P
    Scand J Immunol; 2008 May; 67(5):423-30. PubMed ID: 18363591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti C1q antibodies in cutaneous lupus erythematosus.
    Bălănescu E; Tănăsescu C; Bălănescu P; Olteanu R; Badea C; Petruţescu B; Grancea C; Vagu C; Bleotu C; Ruţă S; Ardeleanu C
    Rom J Intern Med; 2010; 48(2):159-63. PubMed ID: 21428180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between the presence of anti-C1q antibodies and active nephritis in patients with systemic lupus erythematosus.
    Gargiulo Mde L; Gómez G; Khoury M; Collado MV; Suárez L; Álvarez C; Sarano J
    Medicina (B Aires); 2015; 75(1):23-8. PubMed ID: 25637896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance.
    Sinico RA; Radice A; Ikehata M; Giammarresi G; Corace C; Arrigo G; Bollini B; Li Vecchi M
    Ann N Y Acad Sci; 2005 Jun; 1050():193-200. PubMed ID: 16014534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal cell apoptosis in human lupus nephritis: a histological study.
    Faurschou M; Penkowa M; Andersen CB; Starklint H; Jacobsen S
    Lupus; 2009 Oct; 18(11):994-9. PubMed ID: 19762401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-C1q autoantibodies from active lupus nephritis patients could inhibit the clearance of apoptotic cells and complement classical pathway activation mediated by C1q in vitro.
    Pang Y; Yang XW; Song Y; Yu F; Zhao MH
    Immunobiology; 2014 Dec; 219(12):980-9. PubMed ID: 25092568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies against complement C1q specifically target C1q bound on early apoptotic cells.
    Bigler C; Schaller M; Perahud I; Osthoff M; Trendelenburg M
    J Immunol; 2009 Sep; 183(5):3512-21. PubMed ID: 19648280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative anti-C1q antibody titers may influence therapeutic decisions and reduce the number of renal biopsies in systemic lupus erythematosus.
    Moura CG; Mangueira CL; Cruz LA; Cruz CM
    Nephron Clin Pract; 2011; 118(4):c355-60. PubMed ID: 21325866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apoptosis in lupus SLE-N IV and non-lupus mesangiocapillary glomerulonephritis type I MCGN. I. A comparative study.
    Wagrowska-Danilewicz M; Danilewicz M
    J Nephrol; 1998; 11(1):44-9. PubMed ID: 9561485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.